{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:16:00Z","timestamp":1791108960320,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3221,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.fertnstert.2013.04.022","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T22:45:31Z","timestamp":1368571531000},"page":"538-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Transforming growth factor-\u03b21 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation"],"prefix":"10.1016","volume":"100","author":[{"given":"Reshef","family":"Tal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Shohat-Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard V.","family":"Grazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry E.","family":"Malter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.04.022_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib2","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1210\/jc.2009-0492","article-title":"Polycystic ovary syndrome\u2014\u201cA riddle wrapped in a mystery inside an enigma\u201d","volume":"94","author":"Padmanabhan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib4","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1210\/jc.2005-0695","article-title":"Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis","volume":"90","author":"Welt","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fertnstert.2004.05.098","article-title":"Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment","volume":"83","author":"Fleming","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib6","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/humrep\/16.12.2552","article-title":"Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome","volume":"6","author":"Eldar-Geva","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)03154-0","article-title":"Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata","volume":"78","author":"Sozen","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0092-8674(90)90251-9","article-title":"Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation","volume":"62","author":"Laiho","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib9","first-page":"309","article-title":"Mechanisms of transforming growth factor-beta 1-induced cell cycle arrest","volume":"14","author":"Satterwhite","year":"1994","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1083\/jcb.111.2.731","article-title":"Transforming growth factor beta 1\u2013induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane","volume":"111","author":"Yang","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0163-7258(03)00035-4","article-title":"Genealogy, expression, and cellular function of transforming growth factor-beta","volume":"98","author":"Govinden","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/labinvest.3700669","article-title":"Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations","volume":"87","author":"Prud'homme","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0028-1082388","article-title":"TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation","volume":"26","author":"Chegini","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","article-title":"Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called \u201chyperthecosis\u201d","volume":"37","author":"Hughesdon","year":"1982","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humrep\/13.3.651","article-title":"Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries","volume":"13","author":"Agrawal","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib16","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.fertnstert.2010.05.047","article-title":"A variant in the fibrillin-3 gene is associated with TGF-beta and inhibin B levels in women with polycystic ovary syndrome","volume":"94","author":"Raja-Khan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib17","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.2007-0761","article-title":"Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype","volume":"92","author":"Urbanek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib18","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2009-2703","article-title":"Family-based analysis of candidate genes for polycystic ovary syndrome","volume":"95","author":"Ewens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1874312901206010156","article-title":"The role of TGF-beta receptors in fibrosis","volume":"6","author":"Nakerakanti","year":"2012","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib21","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1096\/fj.02-0634rev","article-title":"CD105 is important for angiogenesis: evidence and potential applications","volume":"17","author":"Duff","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib24","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1161\/CIRCULATIONAHA.111.080002","article-title":"Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure","volume":"125","author":"Kapur","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/humupd\/dmi015","article-title":"Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome","volume":"11","author":"Checa","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib27","first-page":"46","article-title":"The intervention effect of Rosiglitozone in ovarian fibrosis of PCOS rats","volume":"25","author":"Miao","year":"2012","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.HYP.36.4.517","article-title":"Transforming growth factor beta in hypertensives with cardiorenal damage","volume":"36","author":"Laviades","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib29","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2003-030508","article-title":"Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women","volume":"88","author":"Romano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.19.10.1113","article-title":"Elevated plasma levels of transforming growth factor-beta 1 in NIDDM","volume":"19","author":"Pfeiffer","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0008-6363(97)00033-3","article-title":"Circulating transforming growth factor beta 1 and coronary artery disease","volume":"34","author":"Wang","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib33","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/molehr\/gal120","article-title":"Polymorphism of the follistatin gene in polycystic ovary syndrome","volume":"13","author":"Jones","year":"2007","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib35","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64322-2","article-title":"Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries","volume":"162","author":"Ferrara","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/09513590600906607","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation","volume":"22","author":"Artini","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib37","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0015-0282(02)04849-5","article-title":"Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome","volume":"79","author":"Amin","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(98)00484-1","article-title":"The pathogenesis of ovarian hyperstimulation syndrome: in\u00a0vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor","volume":"71","author":"Pellicer","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yexmp.2006.12.003","article-title":"Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis","volume":"83","author":"Higashiyama","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib41","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.ki.5001775","article-title":"IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy","volume":"70","author":"Moon","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.fertnstert.2013.04.022_bib42","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-06-1811","article-title":"Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats","volume":"13","author":"Laping","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213005189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213005189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:37:32Z","timestamp":1771393052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213005189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0015028213005189"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.04.022","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming growth factor-\u03b21 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}